Tower Research Capital (TRC)’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$55 Buy
+25
New +$56 ﹤0.01% 5781
2025
Q3
– Sell
-9,332
Closed -$27.7K – 5683
2025
Q2
$27.7K Buy
9,332
+6,184
+196% +$18K ﹤0.01% 3465
2025
Q1
$10.2K Sell
3,148
-1,051
-25% -$3.62K ﹤0.01% 3668
2024
Q4
$16.6K Buy
4,199
+2,808
+202% +$19.1K ﹤0.01% 3349
2024
Q3
$10.8K Buy
1,391
+1,358
+4,115% +$8.92K ﹤0.01% 3722
2024
Q2
$170 Sell
33
-1,084
-97% -$8.36K ﹤0.01% 5424
2024
Q1
$9.08K Buy
1,117
+1,065
+2,048% +$6.1K ﹤0.01% 3901
2023
Q4
$208 Buy
+52
New +$207 ﹤0.01% 5650
2023
Q2
– Sell
-236
Closed -$1K – 6394
2023
Q1
$1K Buy
236
+65
+38% +$242 ﹤0.01% 5631
2022
Q4
$1K Sell
171
-2,400
-93% -$8.18K ﹤0.01% 5684
2022
Q3
$9K Sell
2,571
-28,057
-92% -$132K ﹤0.01% 4705
2022
Q2
$172K Buy
30,628
+28,003
+1,067% +$188K ﹤0.01% 1883
2022
Q1
$23K Buy
2,625
+1,374
+110% +$13.8K ﹤0.01% 3408
2021
Q4
$14K Buy
1,251
+451
+56% +$5.87K ﹤0.01% 4120
2021
Q3
$10K Sell
800
-704
-47% -$11.2K ﹤0.01% 4347
2021
Q2
$25K Sell
1,504
-765
-34% -$13K ﹤0.01% 3694
2021
Q1
$39K Buy
2,269
+1,568
+224% +$29.3K ﹤0.01% 3341
2020
Q4
$11K Sell
701
-10,139
-94% -$187K ﹤0.01% 4264
2020
Q3
$207K Buy
10,840
+8,369
+339% +$144K ﹤0.01% 2543
2020
Q2
$34K Buy
2,471
+1,497
+154% +$21K ﹤0.01% 3364
2020
Q1
$10K Sell
974
-3,951
-80% -$64.3K ﹤0.01% 2039
2019
Q4
$92K Buy
+4,925
New +$63.4K 0.01% 988
2019
Q2
– Sell
-2,586
Closed -$29K – 4384
2019
Q1
$29K Buy
+2,586
New +$21K ﹤0.01% 2074
2018
Q1
– Sell
-4,421
Closed -$17K – 3915
2017
Q4
$17K Buy
+4,421
New +$18.6K ﹤0.01% 2199
2017
Q1
– Sell
-610
Closed -$6K – 4016
2016
Q4
$6K Sell
610
-390
-39% -$5.19K ﹤0.01% 2982
2016
Q3
$13K Hold
1,000
– – ﹤0.01% 1895
2016
Q2
$21K Sell
1,000
-1,281
-56% -$18.5K ﹤0.01% 2199
2016
Q1
$22K Buy
+2,281
New +$18.9K ﹤0.01% 1283
2015
Q4
– Sell
-2,068
Closed -$30K – 5117
2015
Q3
$30K Buy
2,068
+1,217
+143% +$21.3K ﹤0.01% 1402
2015
Q2
$16K Buy
+851
New +$17.7K ﹤0.01% 2299

Other funds holding XBIT

Tower Research Capital (TRC)'s XBIT Position: Q3 2026 in Review

Tower Research Capital (TRC) opened a new position in XBiotech (XBIT) in Q3 2026: 25 shares worth $55. The stake represents ﹤0.01% of the portfolio and ranks #5781 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in XBIT as recently as Q2 2025.

Tower Research Capital (TRC) first reported a position in XBIT in Q2 2015 and has held it in 30 quarters since. The position peaked at $207K in Q3 2020. 34 funds tracked by Wall St. Rank hold XBIT as of Q3 2026.

  • Tower Research Capital (TRC) held 25 shares of XBiotech worth $55 as of Q3 2026.
  • XBiotech was a new Tower Research Capital (TRC) position in Q3 2026.
  • XBiotech made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5781 holding.
  • Tower Research Capital (TRC) first reported a position in XBiotech in Q2 2015 and has held it in 30 quarters since.
  • Tower Research Capital (TRC)'s XBiotech position peaked at $207K in Q3 2020.
  • 34 funds tracked by Wall St. Rank held XBiotech as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.